Abstract
Microangiopathic hemolytic anemia (MAHA) is a well-described complication of stem cell transplantation. Plasmapheresis is one modality utilized as therapy for patients who develop this complication. However, plasmapheresis may alter whole blood levels of certain medications and its effect on tacrolimus in bone marrow transplant patients is unknown. Because tacrolimus has a narrow therapeutic range, the effect of plasmapheresis on whole blood concentrations would be important to know. We report three allogeneic BMT patients who were receiving tacrolimus as acute GVHD therapy while undergoing plasmapheresis for MAHA. Tacrolimus levels seemed unaffected by plasmapheresis in these patients. Bone Marrow Transplantation (2000) 25, 449–451.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tzakis AG, Abu-Elmagd K, Fung JJ et al. FK506 rescue in chronic graft-versus-host disease after bone marrow transplantation Transplant Proc 1991 23: 3225–3227
Koehler MT, Howrie D, Mirro J et al. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 1995 15: 895–899
Nash R, Etzionir, Storb R et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study Blood 1995 85: 3746–3753
Wingard JR, Nash RA, Przepiorka D et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after JHLA-identical sibling bone marrow transplantation Biol Blood Marrow Transplant 1998 4: 157–163
Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Marciniak E, Bailey K, Henslee-Downey PJ, Thompson JS . Bone marrow purging of T lymphocytes with T10B9 monoclonal antibody and complement. In: EM Areman (ed). Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. FA Davis: Philadelphia 1992 pp 208–210
Venkataramanan R . Swaminathan A, Prasad T et al. Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 1995 29: 404–430
Jusko WJ, Piekoszewski W, Klintmalm GB et al. Pharmacokinetics of tacrolimus in liver transplant patients Clin Pharmacol Ther 1995 57: 281–290
Mekki Q, Lee C, Aweeka F et al. Pharmacokinetics of tacrolimus (FK506) in kidney transplant patients Clin Pharmacol Ther 1995 53: 238 (Abstr.)
Boswell GW, Bekersky I, Fay J et al. Tacrolimus pharmacokinetics in BMT patients Bone Marrow Transplant 1998 21: 23–28
Kershner RP, Fitzsimmons WE . Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 1996 62: 920–926
Winkler M, Ringe B, Baumann J et al. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK506 for immunosuppression Clin Chem 1994 40: 2247–2253
McMaster P, Mirza DI, Ismail T et al. Therapeutic drug monitoring of tacrolimus in clinical transplantation Ther Drug Monit 1995 17: 602–605
Przepiorka D, Suzuki J, Ippoliti C et al. Blood tacrolimus concentration unchanged by plasmapheresis Am J Hosp Pharm 1994 51: 1708
Jusko WJ, D'Ambrosio R . Monitoring tacrolimus concentrations in plasma and whole blood Trans Proc 1991 23: 2732–2735
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hale, G., Reece, D., Munn, R. et al. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. Bone Marrow Transplant 25, 449–451 (2000). https://doi.org/10.1038/sj.bmt.1702174
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1702174
Keywords
This article is cited by
-
Effect of plasmapheresis on drug pharmacokinetics in children: a structured review of the current literature
Intensive Care Medicine – Paediatric and Neonatal (2024)
-
Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange
Neurocritical Care (2021)